PRCT vs ROP · rev $224.5M vs P/E 41, rev $1.88B
Procept Biorobotics Corp (PRCT) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
PRCT currently screens at market cap $1.52B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the PRCT and ROP stock pages for the full models.
Not investment advice.